010600 — WellBiotec Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro Cap

Annual balance sheet for WellBiotec Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	ARS/A	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,301	7,924	13,626	15,284	8,327
Net Total Accounts Receivable
Net Total Receivables	14,214	26,928	25,559	12,084	12,155
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	29,929	124,386	46,932	38,747	23,970
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,405	1,872	1,756	4,046	2,034
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	70,921	139,383	59,285	60,241	31,948
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	41,740	100,661	22,640	20,570	10,726
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	51,935	102,840	24,517	22,235	11,765
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	18,986	36,544	34,769	38,006	20,183
Total Liabilities & Shareholders' Equity	70,921	139,383	59,285	60,241	31,948
Total Common Shares Outstanding